Dr. Ulrich is the executive director of the Comprehensive Cancer Center at Huntsman Cancer Institute (HCI). She is also a Jon M. and Karen Huntsman Presidential Professor in Cancer Research in the Department of Population Health Sciences at the University of Utah.
As cancer center executive director, Dr. Ulrich oversees HCI’s academic consortium of more than 200 cancer research teams. She is a cancer epidemiologist whose research focuses on lifestyle and biologic factors in cancer prevention and cancer prognosis.
Dr. Ulrich leads an interdisciplinary team of scientists on research related to the prevention, epidemiology, prognosis, and survivorship of cancer. She is also principal investigator of the HCI Total Cancer Care Protocol in the ORIEN network of cancer centers.
Dr. Ulrich’s lab has performed landmark research on colorectal cancer prevention and survivorship, including studies on biomarkers, aspirin, and connections between obesity and physical activity in cancer prevention and survivorship. She is the author of over 400 publications, and has served as principal investigator on more than 20 competitively funded research studies and clinical trials. She is a former Fulbright scholar, an elected member of the European Academy of Cancer Sciences, a member of the Executive Leadership in Academic Medicine (ELAM) program, and serves on numerous editorial boards and advisory boards for agencies such as the National Institutes of Health (NIH), National Academies of Sciences and Medicine (NASEM), International Agency for Research on Cancer (IARC), and the American Association for Cancer Research (AACR).
Dr. Ulrich has participated in advocacy efforts of the American Association of Cancer Institutes (AACI), served on AACI’s Conflict of Interest Task Force, and has successfully led Huntsman Cancer Institute’s core grant renewal in 2019.
“AACI is an amazing organization and together, as cancer center leaders, we can make a big difference,” says Dr. Ulrich. “I truly look forward to bringing my energy and skills in the service of AACI to address questions of NCI relations and legislative initiatives, COVID- 19 management and recovery, conflict of interest, and any other issues of relevance to AACI members.”